| Literature DB >> 30379901 |
Jung Han Choi1, Ying Li1, Seon Ho Kim2, Rujun Jin1,3, Yung Hui Kim1, Won Choi1, In Cheon You4, Kyung Chul Yoon1,3.
Abstract
PURPOSE: To investigate the influences of smartphone use on ocular symptoms, status of the tear film, and oxidative stress indices in the tears and at the ocular surface.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30379901 PMCID: PMC6209417 DOI: 10.1371/journal.pone.0206541
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow chart showing subject enrollment, allocation, follow up, and analysis.
Baseline characteristics of participants.
| Characteristics | Smartphone group (N = 50) | Control group (N = 30) |
|---|---|---|
| Age (y) | 25.52 ± 2.92 | 26.70 ± 2.98 |
| Sex (male/female) | 33/17 | 17/13 |
| TBUT (s) | 6.76 ± 2.03 | 6.35 ± 2.30 |
| NIKBUT (s) | 10.26 ± 6.13 | 11.84 ± 6.97 |
| Schirmer test (mm) | 13.66 ± 4.10 | 13.85 ± 3.15 |
| KEP (0–9) | 0.26 ± 0.54 | 0.35 ± 0.59 |
| TMH (mm) | 0.20 ± 0.05 | 0.21 ± 0.05 |
Data are expressed as the mean ± standard deviation.
TBUT, tear break up time; NIBUT, non-invasive keratograph break up time; KEP, keratoepitheliopathy; TMH, tear meniscus height.
Fig 2Changes in the ocular surface disease index (OSDI) scores.
OSDI total (A), OSDI symptom (B), OSDI visual function (C), and OSDI trigger (D). *P < 0.05 versus baseline. **P < 0.05 versus 1 h. †P < 0.05 between the two groups.
Fig 3Changes in visual analogue scale (A) and computer vision syndrome scores including fatigue (B), burning (C), dryness (D), blurred vision (E), and dullness (F). *P < 0.05 versus baseline. **P < 0.05 versus 1 h. †P < 0.05 between the two groups.
Fig 4Changes in tear break up time (TBUT, A), non-invasive kertograph break up time (NIKBUT, B), Schirmer test (C), keratoepithelioapthy (KEP, D) and tear meniscus height (TMH, E). *P < 0.05 versus baseline. **P < 0.05 versus 1 h.
Fig 5Concentrations of hexanoyl lysine (HEL, A), 4-hydroxy-2-nonenal (4-HNE, B), malondialdehyde (MDA, C) and 8-oxo-2’-deoxyguanosine (8-OHdG, D) in the tear film. * P < 0.05 versus baseline. ** P < 0.05 versus 1 h.
Fig 6Reactive oxygen species production in the conjunctival epithelium afater smartphone use measured through 2’,7’-dichlorodihydrofluorescein diacetate.
*P < 0.05 versus the baseline value. †P < 0.05 between the two groups.
Changes in the ocular surface disease index scores, visual analogue scale, computer vision syndrome scores, status of the tear film, oxidative stress markers, and dichlorodihydrofluorescein fluorescein intensity production after use of the smartphone and computer display (control).
| Parameters | Smartphone group (N = 50) | Control group (N = 30) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 1 h | 4 h | Baseline | 1 h | 4 h | ||||
| | 15.08 | 17.63 | 25.03 | 12.44 | 14.47 | 16.61 | |||
| | 6.20 | 7.80 | 10.20 | 5.50 | 6.83 | 7.17 | |||
| | 4.88 | 5.50 | 8.50 | 4.17 | 4.58 | 5.83 | |||
| | 4.00 | 4.33 | 6.33 | 2.78 | 3.06 | 3.61 | |||
| 0.54 | 1.30 | 2.26 | 0.46 | 1.30 | 2.23 | ||||
| | 0.68 | 1.50 | 2.34 | 0.50 | 1.17 | 1.40 | |||
| | 0.14 | 0.48 | 0.94 | 0.10 | 0.23 | 0.33 | |||
| | 0.78 | 1.56 | 2.20 | 0.73 | 0.70 | 1.30 | |||
| | 0.26 ± 0.69 | 0.40 ± 0.53 | 0.38 ± 0.53 | 0.23 ± 0.43 | 0.30 ± 0.47 | 0.33 ± 0.48 | |||
| | 0.36 ±0.77 | 0.44 ± 0.61 | 0.52 ± 0.71 | 0.33 ± 0.48 | 0.43 ± 0.50 | 0.43 ± 0.50 | |||
| | 6.76 | 6.42 | 6.06 | 6.35 | 6.94 | 6.05 | |||
| | 10.26 | 9.85 | 8.72 | 11.84 | 9.98 | 9.99 | |||
| | 13.64 ± 2.85 | 13.58 ± 3.80 | 13.26 ± 3.21 | 13.85 ± 3.15 | 13.15 ± 3.36 | 12.50 ± 2.59 | |||
| | 0.26 ±0.56 | 0.28 ± 0.54 | 0.3 ± 0.58 | 0.35 ± 0.59 | 0.40 ±0.60 | 0.45 ± 0.60 | |||
| | 0.20 ± 0.05 | 0.22 ± 0.56 | 0.22 ± 0.08 | 0.21 ±0.05 | 0.24 ± 0.50 | 0.24 ± 0.12 | |||
| | 268.49 | 270.40 | 282.53 | 266.08 | 267.83 | 277.02 | |||
| | 10.08 | 10.22 | 10.54 | 9.76 | 9.64 | 9.68 | |||
| | 44.01 | 43.38 | 45.14 | 41.90 | 45.48 | 44.73 | |||
| | 14.69 | 14.51 | 15.61 | 15.28 | 14.45 | 14.95 | |||
| 107.90 ± 27.54 | 121.42 ± 28.31 | 141.56 ± 22.39 | 108.73 ± 14.48 | 118.37 ± 10.49 | 123.03 ± 18.45 | ||||
Data are expressed as mean ± standard deviation.
OSDI, ocular surface disease index; VAS, visual analogue scale; CVS, computer vision syndrome; TBUT, tear break-up time; NIKBUT, non-invasive keratograph break-up time; KEP, keratoepitheliopathy; TMH, tear meniscus height; HEL, hexanoyl lysine; 4-HNE, 4-hydroxy-2-nonenal; MDA, malondialdehyde; 8-OHdG, 8-oxo-2’-deoxyguanosine; DCF, dichlorodihydro-fluorescein.
*P < 0.05 versus baseline.
**P < 0.05 versus 1 h.
†P < 0.05 between the two groups